DIAGNOSTIC BIOMARKER REAGENTS ASSAYS

Brand Owner (click to sort) Address Description
DAWN Venn Biosciences Corporation Fifth Floor 2 Tower Place South San Francisco CA 94080 Diagnostic biomarker reagents and assays for medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in cancer detection, diagnosis, and treatment monitoring;Medical testing for diagnostic or treatment purposes; medical diagnostic collection, testing, screening, reporting services; Medical testing for diagnostic or treatment purposes, namely, medical diagnostic testing, analyzing test results, researching treatments and therapies, and prognostics for treatments and therapies; medical diagnostic collection and testing of bodily fluids and biological samples for medical diagnostics, medical screening, and medical diagnostic reporting services;
GLORI Venn Biosciences Corporation Fifth Floor 2 Tower Place South San Francisco CA 94080 Diagnostic biomarker reagents and assays for medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in cancer detection, diagnosis, and treatment monitoring;Medical testing for diagnostic or treatment purposes, namely, medical diagnostic testing, analyzing test results; medical diagnostic collection and testing of bodily fluids for medical diagnostics, medical screening, and medical diagnostic reporting services;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods and compositions for identifying high-grade cervical disease in a patient sample are provided. The methods of the invention comprise detecting overexpression of at least one biomarker in a body sample, wherein the biomarker is selectively overexpressed in high-grade cervical disease. In particular claims, the body sample is a cervical smear or monolayer of cervical cells. The biomarkers of the invention include genes and proteins that are involved in cell cycle regulation, signal transduction, and DNA replication and transcription. In particular claims, the biomarker is an S-phase gene. In some aspects of the invention, overexpression of a biomarker of interest is detected at the protein level using biomarker-specific antibodies or at the nucleic acid level using nucleic acid hybridization techniques. Kits for practicing the methods of the invention are further provided.